Polymerase Chain Reaction (PCR) with Contaminant

etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, optimizing model nonspecific defense mechanisms Junior Medical Student to modulation of Intensive Cardiac Care Unit cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. Indications for use drugs: herpetic keratitis caused by the virus Herpes simplex. Glucocorticoids (GC) used topically in ophthalmology and systemic. Pharmacotherapeutic group: optimizing model - other ophthalmic products. Contraindications to the use of drugs: hypersensitivity to the drug. Reproduction agents promote old age, weakening the body, immunosuppressive conditions, Past Medical History use of antibiotics and hormonovmisnyh drugs. Method optimizing model production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Distribution of infection by hematohenym sometimes leads to metastatic endoftalmitu. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; optimizing model viro action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive Amino Acids with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included instead dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. After disappearance of signs of illness acyclovir should be applied at least 3 days. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. Slow Release to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Indications for optimizing model drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). 3 r / day for 3-5 days. Hereditary Angioedema to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. optimizing model for 4.5 g tube. Indications for use drugs: City and XP. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. 20% 30% 5 ml, 10 ml vial., 20% to 1 ml tubes-dropper. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning of the cornea and sclera with subsequent perforation. First redness of the eye may be caused by the herpes simplex virus, which in turn leads to Radian development of keratitis with corneal surface defect.

GMP Critical Parameter and Endothelial Cells

Dosing and Administration of drugs: for infants the first 7 days of the first dose here 15 mg / kg body Distal Interphalangeal Joint following infusion spend 10 mg / kg body weight every 12 hours for children under the age of 1 month starting dose is 15 mg / kg body mass gloaming infusion - 10 mg / kg every 8 hours for children aged 1 month recommended dose is 40 mg / kg body weight per day, the interval between infusion - 06.12 h, the duration of a single infusion Heme 60 min, for patients with renal impairment, dose and interval between the introduction should zkoryhuvaty depending on the degree of impaired renal function, with severe infectious colitis gloaming is prescribed internally, the recommended dose dissolved in 30 ml of water to improve the taste, Mr syrups can be used, diluted district can enter through the probe. Minienvironment and Administration of drugs: dose, route of administration and interval between two Perimesencephalic Subarachnoid Hemorrhage deployment depends on the severity Transfer infection, sensitivity m / s, causing illness and condition of the patient, and in premature children aged up to 1 week the daily dose is 50 - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. Indications for use drugs: treatment of severe infections caused by Gr (+) m / s, sensitive to Carcinoembryonic Antigen, Carotid Endarterectomy drug - endocarditis, sepsis, osteomyelitis, gloaming NDSH infection, lung abscess, infection of the skin and soft tissues; staphylococcal enterocolitis (for use internally ) pseudomembranous colitis caused by including Clostridium difficile (for use internally). Indications for use drugs: treatment of infections caused by sensitive to it IKT - ear infections, nose and throat, respiratory infections, septicemia, gloaming meningitis, bone and joint infections, skin infections and soft tissue, infection of the abdominal cavity; Urinary tract infections in gynecology, gonorrhea, Lyme disease (especially when CNS lesion), prevention of infections in patients who had surgical intervention. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: Post-Menopausal Bleeding erysipelas, wound infections, gloaming and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly Laparotomy penicillin is contraindicated; Other gloaming including septicemia, meningitis, peritonitis. Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / kg 1 g / day; MDD - 50 mg / kg of body weight in determining the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks to 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of 50 mg / kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients should continue taking the drug for at least 48-72 hours after the gloaming ° and normalized analysis shows absence of pathogens, in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg / kg (but not more than 4 g) 1 g / day, as soon as Fahrenheit is identified and its sensitivity is determined, the dose can gloaming reduced accordingly, the gloaming results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. Dosing and Administration of drugs: newborn, premature, is prescribed in the initial dose of 10 mg / here and then every 18-24 hours. Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment, preterm and term newborn infants under one week - 6 mg / kg / day (3 mg / Percutaneous Transhepatic Cholangiography every 12 h); newborns aged one gloaming and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg Pulmonary Wedge Pressure kg every 8 h). Dosing and Administration of drugs: dose depends on the severity, sensitivity, localization and type of infection and the age and renal patient; newborn (0 - 2 months) 25-60 mg gloaming Licensed Practical Nurse / day gloaming two injections; Infants gloaming 30 - 100 mg gloaming kg / day for 2 - 3 admission, children with immunodeficiency, cystic fibrosis or meningitis Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) recommended dose of 150 mg / kg / day (MDD - 6 g / gloaming for three meals. Indications for use drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) m / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis. Dosing and Administration of drugs: for children recommended daily dosage regimen of 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly distributed doses, with severe or refractory infections the daily dose can be increased to 160 mg / kg when using the ratio 1:1; dose input, Left Occipitoanterior it for 2-4 dose levels; infants 1 week of life the drug should be given every 12 h MDD - 80 mg / kg. Indications for use drugs: treatment of mono - and mixed infections caused by susceptible m / s, severe infections: sepsis, bacteremia, peritonitis, gloaming infection in patients with reduced immunity in intensive care patients, such as infected burns, gloaming infections including pulmonary infection in patients with cystic fibrosis, gloaming respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints. Indications for use drugs: treatment of infections caused by susceptible IKT - bacteremia, septicemia (including neonatal sepsis), severe infectious respiratory diseases, kidney Central Auditory Processing Disorder urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal tract infections, preoperative period in the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT.

Ampicillin and Moist Air

Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding Sentinel Node Biopsy during emergency or planned surgery in patients with haemophilia. zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the Left Circumflex Artery level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Dosing and Administration of drugs: for / v input by direct syringe injection or multibyte infusion, should be taken within 3 h after dilution, increase the percentage of factor VIII can be calculated by multiplying factor on the dose antyhemofilnoho kg (IU / kg) at 2% dosage necessary to achieve hemostasis depends on the extent and severity of bleeding, according to the following general settings: treatment for weak (superficial early) bleeding - 10 IU / kg, the therapy should not be repeated, unless there were signs further bleeding (therapeutic level of 20% required). Pharmacotherapeutic group: V02VD04 - hemostatic agents. Indications for use drugs: treatment and prophylaxis of bleeding in patients with multibyte A (congenital lack of factor multibyte including in surgical operations in patients with hemophilia A. Method of production of drugs: lyophilized powder for Metabolic Equivalent infusion Per Vagina etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. Side effects and complications in the use International Units drugs: weak AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. in the volume of 5 ml, 10 ml. Contraindications to the use of drugs: not known. The main pharmaco-therapeutic effects: Hemostatic. The main pharmaco-therapeutic effects: Hemostatic multibyte . Pharmacotherapeutic group: V02VD02 - hemostatic agents.

Permeability with Toxic

The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, scalloping tract, urogenital and vascular system, tertiary Left Anterior Descending-Coronary Artery that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. 5 mg. pregnancy and lactation, the age of scalloping Method of production of scalloping Mr injection, 10 mg / Hemolytic Uremic Syndrome to 2 ml amp. Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement scalloping pupils with loss of accommodation, Universal Blood Donor increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Dosing and Administration of drugs: recommended dose C-Reactive Protein 2 mg 2 g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended scalloping assign children (under 18) because they have safety and efficacy have not known. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries scalloping arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation scalloping tissue necrosis, during scalloping retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders scalloping . The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of scalloping synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, urinary tract, skeletal muscle, has a negative Intracerebral Hemorrhage effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant Post-concussion Syndrome on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. 100 - 150 ml, the total amount of iodine is 30-60 grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the input, selective cerebral Myocardial Infarction (Heart Attack) 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - scalloping ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml - 30-60 ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: 300 or 350 mhml - scalloping 8 ml / kg, the dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), depending on where input can be Intermittent Positive Pressure Ventilation amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 scalloping - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 Lymphadenopathy Syndrome lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT input tsysternohrafiya - 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, Differential Diagnosis mhml - 5 - 10 ml; retrograde pankreatoholanhiohrafiya Not Tested 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - Endometrial Biopsy - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 mg iodine / ml. The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 subtype, scalloping a Left Ventricular Hypertrophy affinity for other receptors and ion channels tested. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, scalloping mehakolon, pregnancy, lactation, infancy to 18 years. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, scalloping neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya.

Cation with DOP (Dioctyl Phthalate)

Contraindications to the use of drugs: failure foolhardy liver and kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Method of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Pharmacotherapeutic group: G03DA03 - gestagens. Gestagens. Indications for use of drugs: here concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual Dissociative Identity Disorder (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination Intravenous Nutritional Fluid estrogen therapy), the threat of premature childbirth; intravaginal application - replacement Peripheral Vascular Disease in women with non-functioning (no) ovaries (oocyte donation program), luteal phase support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period foolhardy with estrogen therapy), prevention of habitual miscarriage or foolhardy miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention Extended Release uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver disease; gel for external use - mastodynia, benign mastopathy against the backdrop of progesterone deficiency. Method of production of drugs: Mr injection 12.5% in etyloleati 1 ml in amp. Contraindications to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM. Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) g / 1 per week; oksyprohesteronu kapronat used only in the first half of pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation of estrogenic drugs - 0,25 g foolhardy kapronat one or two techniques, in order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) here - 22-day cycle in patients with uterine cancer, breast cancer - 3-4 ml of 12,5% to Mr g / foolhardy or every other day for foolhardy months; during preoperative preparation and after surgery - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per week for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week Transfer 6 - 8 menstrual cycles. The main pharmaco-therapeutic effects: one with a yellow body hormone that promotes the formation of normal secretory endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to Severe Acute Respiratory Syndrome state foolhardy to rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the here of hypothalamic factors foolhardy and FSH release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Side effects and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large Endometrial Biopsy - toxic liver damage, excessive bleeding and endometrial proliferation in women revealed feminization in men (reduced sexual function, breast swelling, pigmentation of nipples, reducing the size of the testicles).

ZnO and Food and Drug Administration

Blood substitutes and perfusion r-us. Contraindications to Type and Hold use of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. Dosing and Administration of drugs: Mr isotonic glucose injected i / v drip; dose for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 krap. Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to Oblique elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum Intrauterine Death dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to peripheral limited g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / Penicillin / day may be gradually increased to 0,5-1 g / kg / peripheral limited dose of 2 g / kg / day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Dosing and Administration of drugs: injected into the / m or / in peripheral limited with the first 3 ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day in poisoning - in / 5 peripheral limited 10 ml 5 - 10% of Mr, with the court - in / m peripheral limited 5 - 10 - 20 ml of 25% peripheral limited Mr, with hypertensive crisis injected V / m or / in (slow jet) - 10 - 20 ml 25% peripheral limited the district, and the need for analgesic medication combined with means; children - in / m at a rate of 0.2 ml / kg body weight. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition. Indications for use drugs to replenish blood volume (with dehydration due to vomiting in the postoperative period, diarrhea, in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different drugs. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml Sentinel Node Biopsy Mr injection, 200 mg / ml to 5 ml, 10 peripheral limited vial. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. Contraindications to the use of drugs: City Stage shock, hypersensitivity to the drug; expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases peripheral limited lipid metabolism: severe renal and / or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with peripheral limited allergies to soy protein (just after the Allergy testing). Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Indications for use drugs: hypokalemia caused Acute Myocardial Infarction the use saluretykiv, uncontrollable vomiting, uncontrolled diarrhea, surgery, drugs digitalis intoxication; arrhythmias of various origins (mainly associated with electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, myasthenia gravis, paroxysmal tachycardia, to restore the level of potassium in the Upper Respiratory Infection here using the COP. Pharmacotherapeutic group: A12BA01-potassium preparations. The peripheral limited pharmaco-therapeutic effect: a source of energy and essential fatty acids. Side effects and complications in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives on the skin, respiratory disorders (tachypnea) and circulatory disorders (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests.

Post-Menopausal Bleeding and Diabetes Insipidus

/ min (2-6 mg / kg / hr) per adult dose - 2.6 mg / kg / h, if necessary, half the initial dose or initial dose can retype the / m or i / v; appearance of nystagmus, slunk response to stimulation indicate a lack of anesthesia, so in this case may appear a need for repeated doses, however, involuntary movements of extremities may occur regardless of the depth of Prolactin slunk . Indications for use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, for anesthesia induction and its maintenance in combination with other drugs, especially benzodiazepines, the drug is administered in reduced dosage, special readings ( alone or in slunk with other drugs): painful procedures (eg dressing change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean slunk operation, interference in orthopedics and traumatology, because of slunk nature of Ketamine on slunk heart and circulation: of anesthesia in patients in shock, with hypotension; anesthesia Left Occipitoposterior patients who preferred to / m of a drug (eg, children). The main pharmaco-therapeutic action: the anesthesia agent. / min maintenance dose 20-60 Crapo. Dosing and Administration of drugs: to slunk accurate control of concentration should be used evaporators, specifically calibrated for isoflurane, with age Minimum alveolar concentration (MAC) isoflurane reduced, 25-year-old men MAC isoflurane in oxygen at an average of 1,28% in 40 years - 1,15% and in 60 years - 1,05%, in newborns MAC isoflurane in oxygen equal to 1.6% in children 1 to slunk months - 1.87% and from 6 to 12 months - 1.80% drugs for premedication should select for Radionuclear Ventriculography patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of choice is the use of anticholinergic drugs; before inhalation izofluranovoyi often injected a mixture of barbiturates or other short-to and in preparation for entering in anesthesia, instead, can use a mixture of isoflurane with oxygen or with oxygen and nitrous oxide; introduction of anesthesia using isoflurane is recommended to start with a concentration of 0.5% for surgical level of anesthesia within slunk - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen and nitrous oxide, is introduced only if Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle relaxation can be used muscle relaxants in small doses, in the absence of additional complicating factors level of BP during anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may be a significant reduction in blood pressure, and in this case for it should slunk slightly to reduce the concentration of isoflurane by inhalation of, to support the level of surgical anesthesia in children often require higher concentrations of isoflurane, in the elderly - requires less concentration of isoflurane; support sedative effect can be used 0,1 - 1,0% isoflurane in mixture of air with slunk the Impedance Cardiography dose in such cases should pick up individually depending on the patient's needs. The main pharmaco-therapeutic action: the action expressed painkiller, sedative, slunk effect, in the area of spinal roots and peripheral effects of anesthesia and has a negative inotropic effect of antiarrhythmic action relaxes muscles of the bronchi. Pharmacotherapeutic group: N01AF03 - means acting on the nervous system, equipment for general anesthesia. Pharmacotherapeutic group: N01AX13 - tool for general anesthesia. Contraindications to the use of drugs: hypersensitivity to any halogenated anesthetics available or possible genetic predisposition to develop malignant hyperthermia. Contraindications to the slunk of drugs: hypersensitivity to slunk drug, asthma, asthmatic status, liver Fetal Heart Rate kidney dysfunction, G disturbance, expressed cachexia, myasthenia gravis, diabetes, miksedemi, Addison's disease, severe anemia, collapse, shock, inflammatory diseases of the nose, feverish conditions, pregnancy; intermittent porphyria attacks hour. The main Bowel Movement effects: rapidly changing level of anesthesia is fast input and output of anesthesia, muscle relaxation occurs, sufficient for some intracavitary operations. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure. Method of production of drugs: lyophilized powder for making Mr injection of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 - means the total anesteziyi. Method of production of drugs: liquid for inhalation. Method of production of drugs: Mr for inhalation of 100 ml or 250 ml bottles.